Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al .
Zinal S ChhedaSabine MuellerBindu HegdeAkane YamamichiLisa H ButterfieldHideho OkadaPublished in: Journal for immunotherapy of cancer (2023)
Keyphrases